Form 4: BioLife Solutions Officer Sells Shares to Cover Tax Obligations

Karen A. Foster, Chief Quality and Operations Officer of BioLife Solutions, sold 7,869 shares of common stock on April 1, 2025, at a price of $22.66 per share to cover tax withholding obligations.

Summary

• On April 1, 2025, Karen A. Foster, Chief Quality and Operations Officer of BioLife Solutions Inc., sold 7,869 shares of the company's common stock.
• The sale was executed at a price of $22.66 per share.
• Following the transaction, Foster directly owns 195,853 shares of BioLife Solutions Inc.
• The sale was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on January 3, 2023, to cover tax obligations related to the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a routine Form 4 filing, indicating an insider transaction. Such filings are common and provide transparency into the trading activities of company executives. The use of a 10b5-1 plan suggests the insider planned the transaction in advance to avoid accusations of trading on inside information.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but the pre-planned nature of the sale under a 10b5-1 plan mitigates potential concerns.

Key Dates

Keywords

Form 4, BioLife Solutions, BLFS, Karen A. Foster, Stock Sale, Rule 10b5-1, Insider Trading, Chief Quality and Operations Officer